varnimcabtagene autoleucelB-cell acute lymphoblastic leukemiaB-cell malignanciesClinicalTrials.gov
…relapsed/refractory B-cell malignancies received treatment with varnimcabtagene autoleucel (ARI-0001 cells), a CD19-targeted autologous CAR-T product. Dur…